←
The Pittet Lab555 posts
The Pittet Lab avatar

The Pittet Lab

@PittetLab

We aim to acquire missing knowledge to find better ways to fight cancer. Our areas of expertise are immunology and immunotherapy.

◷ Joined May 2017▧ 156 Photos and videos
Nik Joshi avatar
⟳ The Pittet Lab retweeted
Nik Joshi@Joshilabyale·15 Sep 2023

“In other words, DCs are the ‘best supporting actors’ of anti-tumor immunity.” I guess that makes the T cell Marlon Brando!?! “I'm gonna make this tumor cell an offer he can't refuse.“

Post attachment

Happy to share a link to our recent review of dendritic cells in cancer, written together with the great @MempelThorsten @csgarrix and @DiPilatoMauro. Here is a link giving full access to the paper: authors.elsevier.com/a/1hlQ8…

Post attachmentPost attachment
The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

8/ 🙌 Of course, it takes a village to conduct a study like this, so a hearty thank you, and bravo, to all the clinicians, nurses, researchers, bioinformaticians, technicians and many more, who made this study possible.

The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

7/ 🎯 In essence, patient variation isn't just a challenge, it's an opportunity. By harnessing the differences between individuals, the study revealed that a simple yet powerful variable, CS macrophage polarity, is linked to human cancer outcomes.

The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

6/ 🌐 But wait, there's more! These findings weren't limited to head and neck squamous cell carcinoma. The implications extended to other cancer types, highlighting the potentially universal importance of CS macrophage polarity.

The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

5/ 🤝 What's even more intriguing is that CS macrophage polarity acted as a linchpin in a well-coordinated network involving various tumor-associated cell types. This intricate web influenced tumor progression, potentially revealing new targets for therapies.

The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

4/ 🧬 The CXCL9:SPP1 ratio proved to be a powerful prognostic indicator. Tumors with different macrophage polarities had very different clinical outcomes and responses to immunotherapy. 📈📉

The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

3/ ✳️ Macrophages, immune cells with multiple roles, emerged as key components in this study. Instead of using conventional M1 and M2 markers, we defined macrophage polarity using CXCL9 and SPP1 (CS) gene expression. This approach provided remarkable insights!

The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

2/ 🧪 We took on the challenge of deciphering TMEs by studying 52 head and neck squamous cell carcinomas and discovered that tumor-to-tumor variation can reveal intratumoral cellular programs and disease outcomes. 📊

The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

1/ 🌍 Tumor microenvironments (TMEs) are like unique ecosystems within each cancer patient. They control disease progression, but their complexity makes them difficult to study. Here, we explored whether patient-to-patient variations can reveal insightful information about TMEs.

Post attachment
The Pittet Lab avatar
The Pittet Lab@PittetLab·7 Aug 2023

📢 Research Alert! 🧬🔬 🩺 We are super excited that our latest study, led by the great @RubenBill5 & Asa Wirapati, is out: science.org/doi/full/10.1126… We set out to shed some light on the tumor microenvironment and its impact on cancer progression. 🧵